Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 348

1.

The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.

Leinert E, Singer S, Janni W, Harbeck N, Weissenbacher T, Rack B, Augustin D, Wischnik A, Kiechle M, Ettl J, Fink V, Schwentner L, Eichler M.

Clin Breast Cancer. 2017 Apr;17(2):100-106. doi: 10.1016/j.clbc.2016.10.008. Epub 2016 Oct 19.

PMID:
27884722
2.
3.

Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302).

Geretti E, Leonard SC, Dumont N, Lee H, Zheng J, De Souza R, Gaddy DF, Espelin CW, Jaffray DA, Moyo V, Nielsen UB, Wickham TJ, Hendriks BS.

Mol Cancer Ther. 2015 Sep;14(9):2060-71. doi: 10.1158/1535-7163.MCT-15-0314. Epub 2015 Jul 10.

4.

Protective, elective lung irradiation in non-metastatic Ewing's sarcoma.

Marinova L, Hristozova I, Mihaylova I, Perenovska P.

Radiat Prot Dosimetry. 2015 Jul;165(1-4):492-4. doi: 10.1093/rpd/ncv076. Epub 2015 Jun 24.

PMID:
26113577
5.

Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.

Mumtaz K, Faisal N, Marquez M, Healey A, Lilly LB, Renner EL.

Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):417-22. Epub 2015 Jun 15.

6.

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.

Vulsteke C, Pfeil AM, Maggen C, Schwenkglenks M, Pettengell R, Szucs TD, Lambrechts D, Dieudonné AS, Hatse S, Neven P, Paridaens R, Wildiers H.

Breast Cancer Res Treat. 2015 Jul;152(1):67-76. doi: 10.1007/s10549-015-3437-9. Epub 2015 May 28.

PMID:
26017071
7.

Enhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell lines.

Wójcik M, Lewandowski W, Król M, Pawłowski K, Mieczkowski J, Lechowski R, Zabielska K.

PLoS One. 2015 Apr 30;10(4):e0124955. doi: 10.1371/journal.pone.0124955. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0129639.

8.

Nonrandomized comparison between concomitant and sequential chemoradiotherapy with anthracyclines in breast cancer.

Leonardi MC, Morra A, Santoro L, Balduzzi A, Ivaldi GB, Vischioni B, Ferrari A, Fodor C, Dell'Acqua V, Cardinale DM, Cipolla C, Luini A, Colleoni M, Jereczek-Fossa BA, Orecchia R.

Tumori. 2015 Jan-Feb;101(1):64-71.

PMID:
25702665
9.

Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.

Biswas B, Rastogi S, Khan SA, Shukla NK, Deo SV, Agarwala S, Mohanti BK, Sharma MC, Vishnubhatla S, Bakhshi S.

J Surg Oncol. 2015 May;111(6):683-9. doi: 10.1002/jso.23861. Epub 2014 Dec 29.

PMID:
25557999
10.

[Standard of care and new drugs for diffuse large B-cell lymphoma].

Yamamoto K.

Rinsho Ketsueki. 2014 Oct;55(10):1920-8. Review. Japanese. No abstract available.

PMID:
25297756
11.

Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.

Boutroux H, Cellier C, Mosseri V, Helfre S, Levy C, Desjardins L, Plancher C, Freneaux P, Michon J, Orbach D.

J Pediatr Hematol Oncol. 2014 Nov;36(8):605-12. doi: 10.1097/MPH.0000000000000245.

PMID:
25171453
12.

The management of an orbital diffuse large B-cell lymphoma.

De Stefani A, Boffano P, Bongioannini G.

J Craniofac Surg. 2014 Jul;25(4):e371-3. doi: 10.1097/SCS.0000000000000860.

PMID:
25006952
13.

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

Le Deley MC, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, Le Teuff G, Michon J, Ladenstein R, Marec-Bérard P, van den Berg H, Hjorth L, Wheatley K, Judson I, Juergens H, Craft A, Oberlin O, Dirksen U.

J Clin Oncol. 2014 Aug 10;32(23):2440-8. doi: 10.1200/JCO.2013.54.4833. Epub 2014 Jun 30.

PMID:
24982464
14.

Neoadjuvant treatment with preoperative radiotherapy for extremity soft tissue sarcomas: long-term results from a single institution in Turkey.

Dincbas FO, Oksuz DC, Yetmen O, Hiz M, Dervisoglu S, Turna H, Kantarci F, Mandel NM, Koca S.

Asian Pac J Cancer Prev. 2014;15(4):1775-81.

15.

Myeloma presenting during pregnancy.

Smith D, Stevens J, Quinn J, Cavenagh J, Ingram W, Yong K.

Hematol Oncol. 2014 Mar;32(1):52-5. doi: 10.1002/hon.2088. Epub 2013 Sep 1. No abstract available.

PMID:
23996410
16.

A deeply seated brain metastasis from a primary myxofibrosarcoma: case report.

Wernhart S, Woernle CM, Neidert MC, Bode B, Rushing EJ, Studer G, Fuchs I, Regli L, Sürücü O.

Clin Neurol Neurosurg. 2013 Oct;115(10):2296-8. doi: 10.1016/j.clineuro.2013.07.031. Epub 2013 Aug 6. No abstract available.

PMID:
23962757
17.

Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.

Chen CI, Masih-Khan E, Jiang H, Rabea A, Cserti-Gazdewich C, Jimenez-Zepeda VH, Chu CM, Kukreti V, Trudel S, Tiedemann R, Tsang R, Reece DE.

Br J Haematol. 2013 Aug;162(4):483-8. doi: 10.1111/bjh.12414. Epub 2013 Jun 15.

PMID:
23772701
18.

A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.

Li X, Xia B, Guo S, Zhan Z, Zhang L, Zhao D, Wu X, Zhang Y.

Ann Hematol. 2013 Jun;92(6):807-15. doi: 10.1007/s00277-013-1701-9. Epub 2013 Feb 17.

PMID:
23417758
19.

Spindle cell rhabdomyosarcoma of the prostate.

Latz S, Ellinger J, Goltz D, Marx C, Leuschner I, Müller SC, Fechner G.

Int J Urol. 2013 Sep;20(9):935-7. doi: 10.1111/iju.12082. Epub 2013 Jan 16.

20.

Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.

Fabbri A, Cencini E, Pietrini A, Gozzetti A, Defina M, Fontanelli G, Mazzei MA, Volterrani L, Bocchia M.

Hematol Oncol. 2013 Dec;31(4):213-7. doi: 10.1002/hon.2038. Epub 2012 Nov 14.

PMID:
23161606

Supplemental Content

Loading ...
Support Center